GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gala Pharmaceutical Inc (OTCPK:GLPH) » Definitions » Inventory Turnover

Gala Pharmaceutical (Gala Pharmaceutical) Inventory Turnover : 0.00 (As of May. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Gala Pharmaceutical Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Gala Pharmaceutical's Cost of Goods Sold for the three months ended in May. 2019 was $0.00 Mil. Gala Pharmaceutical's Average Total Inventories for the quarter that ended in May. 2019 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Gala Pharmaceutical Inventory Turnover Historical Data

The historical data trend for Gala Pharmaceutical's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gala Pharmaceutical Inventory Turnover Chart

Gala Pharmaceutical Annual Data
Trend Nov11 Nov12 Nov13 Nov14 Nov15 Nov16 Nov17 Nov18
Inventory Turnover
Get a 7-Day Free Trial - 0.33 - - 2.00

Gala Pharmaceutical Quarterly Data
Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 - - - -

Gala Pharmaceutical Inventory Turnover Calculation

Gala Pharmaceutical's Inventory Turnover for the fiscal year that ended in Nov. 2018 is calculated as

Inventory Turnover (A: Nov. 2018 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Nov. 2018 ) / ((Total Inventories (A: Nov. 2017 ) + Total Inventories (A: Nov. 2018 )) / count )
=0.004 / ((0.002 + 0) / 1 )
=0.004 / 0.002
=2.00

Gala Pharmaceutical's Inventory Turnover for the quarter that ended in May. 2019 is calculated as

Inventory Turnover (Q: May. 2019 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: May. 2019 ) / ((Total Inventories (Q: Feb. 2019 ) + Total Inventories (Q: May. 2019 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gala Pharmaceutical  (OTCPK:GLPH) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Gala Pharmaceutical's Days Inventory for the three months ended in May. 2019 is calculated as:

Days Inventory =Average Total Inventories (Q: May. 2019 )/Cost of Goods Sold (Q: May. 2019 )*Days in Period
=0/0*365 / 4
=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Gala Pharmaceutical's Inventory to Revenue for the quarter that ended in May. 2019 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: May. 2019 ) / Revenue (Q: May. 2019 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Gala Pharmaceutical Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Gala Pharmaceutical's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Gala Pharmaceutical (Gala Pharmaceutical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gala Pharmaceutical Inc (OTCPK:GLPH) » Definitions » Inventory Turnover
Comparable Companies
LSE:PYC PRTX PPCB BTHE TSXV:IBT XCNQ:DOSE TSXV:APC RSPI XCNQ:LILY OBMP ASX:MEB XSAT:CLINE B AMBS WAR:RDG ASX:ACL TNTY TSXV:MFS VODG GOVX ASX:RAC
Traded in Other Exchanges
N/A
Address
18881 Von Karman Avenue, Suite 1440, Irvine, CA, USA, 92612
Website
https://www.galapharmaceuticals.com
Gala Pharmaceutical Inc is a United States-based company engaged in the hemp and cannabidiol (CBD) industry. It is focused on the development, research, and commercialization of products derived from the hemp and cannabis plant. It is focused on CBD flavored thin-film strip which is an advanced method of providing CBD for the dietary supplement. The services offered by the company are the development of cannabinoid-based health and wellness products; development of medical grade compounds; licensing of proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal herb industry. The group earns revenue from the sale of products related to hemp and CBD, including modified electronic cigarettes and vape pens.